Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease

Clicks: 298
ID: 267331
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Mucosal healing (MH) is now considered as a major treatment goal in clinical trials and clinical practice for patients with inflammatory bowel disease (IBD). MH is associated with sustained clinical remission, steroid-free remission, and reduced rates of hospitalization and surgery. There is a well- …
Reference Key
g2016expertcurrent Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Pineton de Chambrun G;Blanc P;Peyrin-Biroulet L;;
Journal expert review of gastroenterology & hepatology
Year 2016
DOI
DOI not found
URL
https://www.pubmed.gov/27043489/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine treatment outcome Remission Induction Colitis Ulcerative / drug therapy* Gastrointestinal Agents / therapeutic use* time factors anti-inflammatory agents / therapeutic use* crohn disease / drug therapy* intestinal mucosa / pathology ulcerative / pathology intestinal mucosa / physiopathology wound healing / drug effects* colon / pathology intestinal mucosa / drug effects* laurent peyrin-biroulet colonoscopy pmid:27043489 doi:10.1586/17474124.2016.1174064 guillaume pineton de chambrun pierre blanc ulcerative / physiopathology colon / drug effects* colon / physiopathology crohn disease / pathology crohn disease / physiopathology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.